Thursday, July 29, 2010
"The source for European pharmaceutical biotechnology news..."
Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.
Issue 4 Executive Interviews
Automated blood sampling
NGP asked DiLab’s Per Dannhusen what to bear in mind when switching to automated blood sampling.
No Comments
Expanding into biotherapeutics
Biotherapeutics, believes Dr. Tim Riley, Vice President and Managing Director of the Pharmaceutical Business Operations at Waters Corporation, is rapidly growing. NGP asked him how Water’s mass spectrometry systems help to characterise these therapeutics in order to control their quality and efficacy.
No Comments
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.